Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ALI HUSSAIN

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1003267006
CMS profile
1637872
Location
GREENVILLE, NC

General Payments · PY2018–2024

$938.81

  • Reported across 31 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$403.07

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $233.09 12
Education $169.98 2

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Incyte Corporation $210.61 6
Alexion Pharmaceuticals, Inc. $69.99 1
Merck Sharp & Dohme Corporation $42.77 3
Alkermes, Inc. $23.38 1
Acerta Pharma LLC $21.04 1
ABBVIE INC. $18.87 1
ARRAY BIOPHARMA INC $16.41 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $145.34 2
PY2019 $121.90 3
PY2020 $37.76 3
PY2023 $230.74 9
PY2024 $403.07 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2018201920202023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $18.87 07/11/2024 Food and Beverage Undisputed 01/23/2026 1103958352 CMS
Alexion Pharmaceuticals, Inc. $69.99 03/08/2024 Education Undisputed 01/23/2026 1093987631 CMS
Alkermes, Inc. $23.38 08/16/2024 Food and Beverage Undisputed 01/23/2026 1120520237 CMS
ARRAY BIOPHARMA INC $16.41 11/21/2024 Food and Beverage Undisputed 01/23/2026 1131394650 CMS
AstraZeneca Pharmaceuticals LP $21.04 10/08/2024 Food and Beverage Undisputed 01/23/2026 1104393461 CMS
Incyte Corporation $15.01 01/25/2024 Food and Beverage Undisputed 01/23/2026 1141197503 CMS
Incyte Corporation $19.23 04/02/2024 Food and Beverage Undisputed 01/23/2026 1141198139 CMS
Incyte Corporation $99.99 04/04/2024 Education Undisputed 01/23/2026 1141316095 CMS
Incyte Corporation $15.76 08/15/2024 Food and Beverage Undisputed 01/23/2026 1141276232 CMS
Incyte Corporation $45.39 10/01/2024 Food and Beverage Undisputed 01/23/2026 1141191011 CMS
Incyte Corporation $15.23 11/14/2024 Food and Beverage Undisputed 01/23/2026 1141277238 CMS
Merck Sharp & Dohme LLC $14.23 02/14/2024 Food and Beverage Undisputed 01/23/2026 1141752164 CMS
Merck Sharp & Dohme LLC $14.19 08/26/2024 Food and Beverage Undisputed 01/23/2026 1141886807 CMS
Merck Sharp & Dohme LLC $14.35 11/07/2024 Food and Beverage Undisputed 01/23/2026 1141752166 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.